Session date: 
Wednesday, November 30, 2016 - 12:00pm to 1:00pm

S. Perwez Hussain, Ph.D.


Head, Pancreatic Cancer Unit

Laboratory of Human Carcinogenesis

National Cancer Institute, NIH


Dr. Hussain’s research is focused on identifying novel therapeutic targets in pancreatic cancer, which is one of the most lethal malignancies. His recent study has identified macrophage migration inhibitory factor (MIF), an inflammatory mediator, as a critical component in disease aggressiveness and a candidate therapeutic target in human pancreatic cancer. Dr. Hussain is the Head of Pancreatic Cancer Unit and his group utilizes a combination of global and targeted translational research strategies, focused on inflammatory mediators, to examine the underlying mechanisms of human pancreatic cancer progression and understand the mechanistic and functional role of a gene or pathway associated with patient’s outcome.

Bluemle Life Sciences Building
233 South 10th Street
Room 101
Philadelphia, PA 19107
United States
Session Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance

Please login or register to take this course.